Cambridge Investment Research Advisors, Inc. Insulet Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Insulet Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 1,790 shares of PODD stock, worth $583,182. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,790
Previous 1,183
51.31%
Holding current value
$583,182
Previous $311,000
80.71%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding PODD
# of Institutions
901Shares Held
63.2MCall Options Held
300KPut Options Held
461K-
Vanguard Group Inc Valley Forge, PA8.71MShares$2.84 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.97 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.74MShares$1.54 Billion0.31% of portfolio
-
State Street Corp Boston, MA3.06MShares$996 Million0.04% of portfolio
-
Baillie Gifford & CO2.14MShares$696 Million0.53% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $22.6B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...